[2P-0689] Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL

〇Lichun Huang¹、Ting-Yu Chang¹、Hsin-An Chen^2,3,4、Ching-Feng Chiu¹、Yi-Wen Chang¹、Tsang-Chih Kuo⁵、Po-Chun Tseng⁶、Weu Wang⁷、Mien-Chie Hung^8,9、Jen-Liang Su^1,6,9,10 (1.National Institute of Cancer Research, National Health Research Institutes, Taiwan.、2.Department of General Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taiwan.、3.Division of General Surgery, Department of Surgery, Shuang Ho Hospital,Taipei Medical University, Taiwan.、4.Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan.、5.Institute of Biochemical Sciences, College of Life Science, National Taiwan University, Taiwan.、6.Department of Biotechnology, Asia University, Taiwan.、7.Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taiwan.、8.Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Texas.、9.Center for Molecular Medicine, China Medical University Hospital, Taiwan.、10.Graduate Institute of Cancer Biology, China Medical University, Taiwan)

Dicer, Paclitaxel Chemosensitization, breast cancer